Approaches To Therapy Escalation In T2D

NCT03813316 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of funding availability to complete project

Conditions

Type2 Diabetes

Interventions

DRUG: DPP-4 inhibitor
DRUG: SGLT2 inhibitor
DRUG: SGLT2 inhibitor and DPP-4 inhibitor

Sponsor

LMC Diabetes & Endocrinology Ltd.

Collaborators

[object Object]
[object Object]